Michael B. Andrews, MD has treated all forms of cancer and blood disorders at Northwest Georgia Oncology Centers, P.C. since 1991. He has a special interest in treating patients with lung, breast and gastrointestinal cancers.
Dr. Andrews currently serves as the Chief Cancer Officer for WellStar Health System and an advisory board member for the Georgia Center for Oncology Research and Education (CORE). He is active in the STAT Lung Cancer Consultation Service and Breast and Gastrointestinal malignancy conferences and actively involved in cancer research and clinical trials to provide his patients with the most advanced cancer treatment available in Georgia.
Dr. Andrews provides patient-centered cancer care at NGOC’s Marietta Cancer Center.
| Personal Data | Birthplace: Evanston, IL |
| Undergraduate Education | BA in Industrial Engineering (High Honor), 1977 Special Studies, Biology & Chemistry, 1980 Georgia Institute of Technology Atlanta, GA |
| Medical Education | Doctor of Medicine Medical College of Georgia Augusta, GA September 1981 – June 1985 |
| Postdoctoral Training | INTERNSHIP Internal Medicine Vanderbilt University, Medical Center Nashville, TN July 1985 – June 1986 RESIDENCY Internal Medicine Vanderbilt University, Medical Center Nashville, TN July 1986 – June 1988 FELLOWSHIP Hematology & Medical Oncology Vanderbilt University, Medical Center Nashville, TN July 1988 – June 1991 |
| Board Certification | American Board of Internal Medicine, Internal Medicine, 1988 American Board of Internal Medicine, Medical Oncology 1991, Recertified 2001 and 2011 American Board of Internal Medicine, Hematology 1994, Recertified 2001, 2011 |
| Medical Licensure | State of Georgia, 1991 (Active) |
| Professional Societies | American College of Physicians American Society of Clinical Oncology Medical Association of Georgia Georgia Society of Clinical Oncology |
| Honors | Chief Cancer Officer, WellStar Health System, 2010-Present Georgia Center for Oncology Research and Education (CORE), Board of Directors President, Georgia Society of Clinical Oncology, 1998 - 2000 President, Alpha Pi Mu, Industrial Engineering Honor Society Phi Kappa Phi, Senior Honor Society Tau Beta Pi, Engineering Honor Society Executive Committee InterVarsity Christian Fellowship |
| Publications | ABSTRACTS: MB Andrews, FA Greco, DH Johnson, JD Hainsworth. "Mitoxantrone, FU, and High Dose Leucovorin: An Effective Well Tolerated Regimen For Refractory Breast Cancer. ASCO Proceedings". Volume 9: 35, March 1990. ARTICLES: JD Hainsworth, MB Andrews, DH Johnson, FA Greco. "Mitoxantrone, Fluorouracil, and High Regimen for Metastatic Breast Cancer". Journal of Clinical Oncology, Volume 9: 1731-1735, October 1991. JD Hainsworth, S Litchy, L Morrissey, MB Andrews, M Grimaldi, M McCarty, FA Greco. “Rituximab Plus Short – Duration Chemotherapy As First – Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network. Journal of Clinical Oncology, Page 1500-1506, March 2005. |
| Major Research Interests | Clinical Trials (Oncology & Hematology) |